Prevail Partners

Portfolio · 1

Omnix Medical

Novel Antibiotic Agents to Combat Resistant Bacteria

1 round $25.0M committed Latest: 2025-10

Investment activity

Q&A

What is Prevail Partners' most recent investment activity?

Prevail Partners participated in a Series C round for Omnix Medical in October 2025, which raised $43.75M.

Which sectors does Prevail Partners focus on for investments?

Prevail Partners has invested in the Health Tech & Life Sciences sector, with Omnix Medical being a notable portfolio company.

What is the typical investment stage for Prevail Partners?

Prevail Partners has participated in a Series C round, specifically for Omnix Medical.

Can you name a key company in Prevail Partners' portfolio?

Omnix Medical, a company developing novel antibiotic agents, is a key company in Prevail Partners' portfolio.

What is Prevail Partners' investment range?

Prevail Partners' investment range is $25M - $25M.